Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Healthtrust
Cantor Fitzgerald
Covington
Merck
Accenture
Fish and Richardson
Citi
UBS

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076681

« Back to Dashboard

NDA 076681 describes KIMIDESS, which is a drug marketed by Vintage Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the KIMIDESS profile page.

The generic ingredient in KIMIDESS is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 076681
Tradename:KIMIDESS
Applicant:Vintage Pharms
Ingredient:desogestrel; ethinyl estradiol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 076681
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KIMIDESS desogestrel; ethinyl estradiol TABLET;ORAL-28 076681 ANDA Par Pharmaceutical 0603-7512 0603-7512-17 6 BLISTER PACK in 1 CARTON (0603-7512-17) > 1 KIT in 1 BLISTER PACK (0603-7512-01) * 5 TABLET, FILM COATED in 1 BLISTER PACK * 21 TABLET, FILM COATED in 1 BLISTER PACK
KIMIDESS desogestrel; ethinyl estradiol TABLET;ORAL-28 076681 ANDA Par Pharmaceutical 0603-7512 0603-7512-49 3 BLISTER PACK in 1 CARTON (0603-7512-49) > 1 KIT in 1 BLISTER PACK (0603-7512-01) * 5 TABLET, FILM COATED in 1 BLISTER PACK * 21 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.15MG,N/A;0.02MG,0.01MG
Approval Date:Apr 30, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Federal Trade Commission
Harvard Business School
UBS
Johnson and Johnson
Teva
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot